false
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Hamburger Menu
Catalog
Partner Programs
Society Store
Clinical Guidelines
Help & Tutorials
Catalog
The Osteocalcin Controversy
The Osteocalcin Controversy
Presentations/Presenters
The Osteocalcin Controversy - Chair
Presenter:
Bente Langdahl, MD, PhD, DMSc (Aarhus University Hospital)
Relationship: Commercial Interest(s)
Advisory Board Member: Amgen Inc
Advisory Board Member: Other (fill in the blank below)
Advisory Board Member: UCB, Gedeon-Richter
Speaker: AstraZeneca
Speaker: Other (fill in the blank below)
Speaker: UCB, Gedeon-Richter, Astellas
Grant Recipient: Amgen Inc
Grant Recipient: Novo Nordisk
The Osteocalcin Controversy - Chair
Presenter:
Roberto Civitelli, MD (Washington Univ-St Louis)
Relationship: Commercial Interest(s)
Advisory Board Member: Ultragenyx.
Consulting Fee: Pharmacosmos. Research Investigator
Ultragenyx.: Ferring Pharmaceuticals, Bayer Schering Pharma.
The Osteocalcin Controversy - Reproduction and Cognitive Effects
Presenter:
Andrea Isidori, PhD, MD (Sapienza University of Rome)
Relationship: Commercial Interest(s)
Advisory Board Member: Amgen Inc, UCB.
Consulting Fee: UCB.
Grant Recipient: Amgen Inc, Novo Nordisk. Research Investigator
The Osteocalcin Controversy - The Clinical Dilemmas
Presenter:
Ann Schwartz, PhD (University of CA-San Francisco)
No relevant financial relationships
Osteocalcin and Glucose Metabolism: What the Mouse Models Tell Us
Presenter:
Fanxin Long, Ph.D. (The Children's Hospital of Philadelphia)
No relevant financial relationships
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
1.5 AMA PRA Category 1 Credits
×
The Osteocalcin Controversy Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Forgot Password
EndoCareers
|
Contact Us
|
Privacy Policy
|
Terms of Use
CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036
202.971.3636 | 888.363.6274
×